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ADDITIVE EFFECT OF INTERFERENTIAL THERAPY OVER
PELVIC FLOOR EXERCISE ALONE IN THE TREATMENT OF
FEMALE URINARY STRESS AND URGE INCONTINENCE: A
RANDOMIZED CONTROLLED TRIAL
Sing Kai Lo, PhD; Jaya Naidu,1 MHA; Yuelong Cao,2 MD
Abstract: This pilot study attempted to examine the additional efficacy of interferential therapy in reducing the
symptoms of urinary stress and urge incontinence. Twenty-four subjects were randomly allocated to the
experimental group, which received interferential therapy plus pelvic floor exercises, or the control group, which
received pelvic floor exercises only. Treatment was given three times a week for 4 weeks. Subjects were given
urinary diaries to record urinary symptoms (including frequency of passing urine and number of times woken
by desire to pass urine) for 5 days prior to and after treatment. Perineometer readings, pad weighing test and
start/stop test were also performed in a physiotherapy clinic before and at completion of treatment regimes.
Significant improvements were observed in all the outcome variables in the experimental group, but in only
the perineometer readings in controls. When the changes from pre- to post-treatment were compared between
the two groups, four of the dependent variables did not reach statistical significance. Power analysis indicated
that the sample size for each group needed to be 70 for all results to be statistically significant. This study
shows that interferential therapy plus pelvic floor exercise appears to be a more effective treatment modality
than pelvic floor muscle strengthening exercise alone for incontinence, but a larger trial with longer follow-
up is needed before definitive conclusions can be reached.
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Introduction
Urinary incontinence in females is a major public health
problem. Approximately 11 million women in the USA
[1] and at least 700,000 Australians of all ages [2] are
affected. It is most common in older women. For example,
at least 50% of nursing home residents in Britain and
North America suffer from the condition [3].
Nevertheless, it is also prevalent among younger women,
especially those of childbearing age. A survey of 1,000
40-year-old women revealed that 9% had urinary
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incontinence weekly or more often [4]. Intuitively, it
may be far more prevalent than detected as many
incontinent people do not seek medical or nursing help
due to the embarrassing nature of the problem [5]. On
the other hand, women of different socioeconomic
backgrounds are equally likely to experience the
symptoms. In a study of 2,000 women in an urban
academic setting and 500 women working in a rural
pottery manufacturing facility, the percentages of
respondents with urinary incontinence at least monthly
were 21% and 29%, respectively [6].
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Urinary incontinence affects not only the sufferers
but also the family, friends and the public due to its
associated medical and social costs. In fact, certain aspects
of urinary incontinence are associated with depression
and sexual dysfunction in ways other than the obvious
[7]. Surgical repair is the most effective treatment for
stress urinary incontinence, although it is not without
complications [8]. It has been suggested that all women
with urinary incontinence should initially be offered
non-surgical therapy since many will obtain satisfactory
results [9].
Management by family physicians (without need for
specialist referral) includes pelvic floor muscle
strengthening exercise (PFE) and lifestyle modifications
[10]. Some potentially modifiable lifestyle factors
associated with urinary incontinence include high body
mass index as well as heavy smoking and tea drinking
[11]. However, changing these factors has limited benefit
in patients with severe incontinence, and the effect of
PFE is not significant enough in the longer term [12].
Levator ani muscle strength improves after PFE and
remains significantly better in long-term follow-up [13].
Hence, women should be counselled about the long-
term efficacy of, and about the necessity of maintaining,
training. Successful use of electrical stimulation in the
management of urinary incontinence was reported as
early as 1975 [14], and the intervention was well tolerated
in elderly nursing home patients [15].
Surprisingly, not many studies to date have
determined whether electrical stimulation has an additive
effect over and above PFE. We therefore designed this
study to examine whether interferential therapy (ITT)
and PFE together was more effective than PFE alone in
the treatment of female stress and urge urinary
incontinence.
Methods
Study design
This was a prospective, blinded, randomized, two-group
trial. Subjects were randomly allocated as soon as they
gave written consent, using the sealed envelope method,
to one of two regimes: PFE or ITT plus PFE. Within each
group, a pre-post design was employed. However, as one
group was treated with ITT, only the assessor but not the
patients could be blinded.
Participants
All patients were recruited from the physiotherapy
department of a regional hospital in Perth, Western
Australia. Female subjects, aged 20 years or older, who
had established urinary incontinence due to stress or
urge were invited to participate. The main criteria for
exclusion were altered mental state, urinary incontinence
caused by problems other than stress or urge, transient
incontinence, or severe disability requiring full assistance
with all acts of daily living. Ethical approval was granted
by the Executive Committee of the Hospital. All
participants gave written informed consent.
It was estimated that about 50 participants in each
group would be sufficient to give 0.8 power at the 0.05
alpha level for a two-sided alternative. Calculation of
sample size was performed using the PASS statistical
software (NCSS, Kaysville, Utah, USA) [16]. Parameters
used in the calculations were derived from Jundt et al
[13] and Lamhut et al [15].
Differential diagnosis
Diagnosis was made using information obtained from
the urinary diary, history and physical examination. For
the purposes of this study, subjects with the presence of
a small volume of leakage that was immediate and
caused by physical effort in the absence of urge were
diagnosed as having stress incontinence. Those with
nocturia, nocturnal enuresis, frequency and losing/
leaking large volumes of urine were diagnosed as having
urge incontinence. When the diagnosis was unclear, or
when these definitions proved unhelpful, the patient
was referred back to either a medical officer or a urologist
for further assessments.
Procedures
Both treatment regimes were completed in the hospital
under the supervision of a physiotherapist. For both
groups, treatment was given three times a week for 4
weeks, making a total of 12 treatment sessions. All
participants were instructed not to receive any other
interventions during the study period, either at home or
in other clinics.
For PFE, subjects assumed the stride half-lying position
with knees bent to 45° flexion. In each treatment session,
ten sets of five contractions were performed, with a 30-
second rest between each set. In the PFE group, this was
repeated after a period of 1 hour or more, making a total
of 100 contractions.
In the ITT + PFE group, 50 pelvic floor contractions
were followed by ITT and then a further 50 contractions.
The Nemectrodyne 5 stimulator (Deutsche Nemectron
GmbH, Daimlerstr, Karlsruhe, Germany) was used for
ITT. For ITT, subjects were in a half-lying position with
pillows under their slightly parted knees. The Laycock
four-pole position method was used to place the electrodes
[17]: two anterior flat electrodes were placed over the
obturator foramen, 1.5 cm to 2.0 cm lateral to the
symphysis, and two posterior electrodes were placed
medial to the ischial tuberosities on either side of the
anus. The anterior electrodes were held in position by
means of a 3 cm cotton belt fastened by Velcro straps. The
subject’s weight held the posterior electrodes in position.
The frequency used ranged from 0 Hz to 100 Hz. It has
been reported that a higher intensity results in more
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effective treatment, because an increased intensity may
recruit more motor units [17]. Therefore, patients
received the maximum intensity that they could tolerate.
The first treatment session lasted for 15 minutes. If no ill
effects were reported, the duration of subsequent
treatment sessions were increased to 30 minutes.
Assessment
The urinary diary, pad weighing test, perineometer
readings and midstream stop/start test were included in
the assessment procedures. Each subject was given a
diary with verbal and written instructions and asked to
record details for 5 days prior to commencement of
treatment and 5 days after completion of treatment. The
diary was designed to assess the severity and types of
symptoms present, as well as frequency and voiding
patterns.
For the pad weighing test, subjects were asked to void
and then given 1,000 mL of water or orange juice. After
1 hour, subjects were given a pre-weighed pad to use
and we attempted to reproduce the symptoms by means
of the following exercises: brisk walk for 5 minutes,
picking up objects from the floor (10 times), jumping on
a mini trampoline (20 times), squatting on the floor from
a standing position (10 times), step-ups (10 times),
jumping on a mini trampoline and coughing (10 times),
and squatting and coughing (10 times). The pad was
then re-weighed.
For perineometer readings, the physiotherapist
inserted the perineometer into the subject’s vagina. The
manometer was set to zero and the subject was asked to
contract their pelvic floor muscles. Five trials were
completed and the last three results were recorded.
For the midstream stop/start test, the subject was
asked to void and given verbal instructions to stop the
stream three times. The result was recorded as either
able to stop midstream urine, able to slow midstream
urine, or no effect. These tests were performed before
the treatment regime commenced and again on
completion of the programme.
Data analysis
Unless otherwise stated, data are reported as mean ±
standard deviation (SD) and analysed following the
intention-to-treat principle. Test–retest reliability was
assessed using the intra-class correlation coefficient
ICC(1,1). Wilcoxon signed rank test and McNemar’s test
were used to compare the outcome measures before and
after treatment for continuous and categorical variables,
respectively. For continuous measures, the difference
between pre- and post-treatment was calculated. We
then compared these differences between the two groups
using the Wilcoxon rank sum test. For categorical
measures, whether improvement (yes vs no) was
observed for each subject was first determined. The
difference in the percentage of subjects improved in
each group was then tested using Fisher’s exact test.
Although the overall level of significance was set at 0.05,
the sharpened Bonferroni procedure was used to adjust
for individual alpha levels when multiple testings were
performed. Power analysis was performed for all non-
significant results.
Results
The test–retest reliability of the perineometer unit was
assessed in 10 normal subjects before the study started.
ICC(1,1) was calculated as 0.95 (95% confidence interval,
95% CI, 0.89, 0.98). The test–retest reliability of the
Nemetrodyne 5 unit was also determined in 10 normal
subjects. ICC(1,1) values were 0.98 (95% CI, 0.93, 1.00)
for minimum intensity and 0.76 (95% CI, 0.70, 0.82) for
maximum tolerable intensity.
Due to limitation of resources, only 24 participants,
12 in each group, could be recruited. The age distribution
was similar in the two groups (PFE vs ITT + PFE, 52.1 ±
17.5 vs 55.1 ± 15.1 years; p = 0.478). The means and SDs
of the continuous outcome measures pre- and post-
treatment are shown in Table 1. The difference between
pre- and post-treatment (improvement) was significant
for all variables in the ITT + PFE group, while the
difference in only one variable (perineometer reading)
was significant in the PFE group, after sharpened
Bonferroni adjustment. When improvement was
compared between the two groups, only one variable
was statistically significant, namely frequency (i.e.
number of times per day urine passed) (Table 2).
Both the stop/start test and urge were discrete variables
with three levels. The percentages of patients with
improvement (i.e. from 3 to 2 or 1, and from 2 to 1) from
pre- to post-treatment in the two groups are presented in
Table 3. Although the differences between the two
groups were not significant in either of the two variables,
the number of improved patients in the ITT + PFE group
was twice that in the PFE group. One participant in the
ITT + PFE group had improvement of two units (from 3
to 1), whereas all improvements in the PFE group were
of one unit only.
Discussion
The adjunct effects of electrical stimulation on the
management of urinary stress and urge incontinence
have been studied [18], but there is little consistency in
the type of stimulation used [19]. This study attempted
to assess the additional effect of ITT when prescribed
together with PFE. Both objective (perineometer reading,
stop/start test, pad weighing test and frequency of urine
passed) and subjective (nocturia and urge) measurements
were used for evaluation. The randomized prospective
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design with a blinded assessor and the similar age
distributions between the two studied groups minimized
the effects of bias and confounding on the outcomes. The
use of non-parametric methods for statistical analysis
also minimized the effect of extreme values on the
comparison of outcome effects.
We noted that of the four variables reported in Table
1, the difference between pre- and post-treatment value
was always larger in the ITT + PFE group. If the two
regimes were equally effective, two of the differences
would be expected to be bigger in the PFE group and two
to be higher in the ITT + PFE group. The probability of all
four outcome measures being larger in the ITT + PFE
group is 0.0625, computed according to the binomial
distribution.
In the PFE group, perineometer readings showed
that six subjects improved while two were weaker, with
a mean strength improvement of 2.0 units. Although
statistically significant, this appears to be slightly lower
than the 4.1 units reported by a study that used an
uncontrolled number of PFEs [20]. The difference could
also be attributable to the different types of perineometers
used. The mean improvement in the ITT + PFE group
was also 2.0 units. This similarity between the two
studied groups is expected, as the perineometer was
used to measure pelvic floor muscle strength and PFE is
already very effective in this respect.
Three subjects in the PFE group and six in the ITT +
PFE group showed improvement in the stop/start test.
No comparison with previous studies could be made, as
Table 1. Continuous outcome measures
PFE ITT + PFEVariable
Pre-treatment Post-treatment p* Pre-treatment Post-treatment p*
Perineometer 7.52 ± 2.44 9.55 ± 3.50  0.003† 6.05 ± 4.82 8.08 ± 4.83 0.001†
7.04 [2.67] 9.18 [3.07] 4.50 [7.10] 6.50 [7.42]
Pad test 5.58 ± 7.73 1.25 ± 1.76 0.023 94.1 ± 164 9.00 ± 29.3 < 0.001†
3.50 [6.00] 0.50 [2.00] 6.00 [178] 0.00 [1.50]
Frequency 6.36 ± 2.18 6.29 ± 2.21 0.418 9.05 ± 3.66 7.24 ± 2.62 < 0.001†
5.60 [3.50] 5.60 [2.70] 8.62 [4.85] 7.16 [4.45]
Nocturia 0.93 ± 0.95 0.45 ± 0.86 0.024 1.85 ± 1.64 0.99 ± 1.04 0.001†
0.60 [2.00] 0.00 [0.60] 1.38 [2.05] 0.93 [1.05]
Values reported are mean ± standard deviation and median [inter-quartile range]. *p values calculated using the Wilcoxon signed rank test;
†still statistically significant after sharpened Bonferroni adjustment. PFE = pelvic floor exercise; ITT = interferential therapy.
Table 2. Improvement after treatment, assessed as the difference between pre- and post-treatment values
Difference from pre- to post-treatment
Variable
PFE ITT + PFE p*
Perineometer 2.03 ± 2.10 2.04 ± 2.47 0.253
2.38 [2.10] 1.20 [2.17]
Pad test 4.33 ± 8.37 85.1 ± 150 0.101
2.50 [4.50] 4.50 [134.0]
Frequency 0.07 ± 1.76 1.81 ± 1.62 0.006†
–0.30 [2.40] 1.46 [1.93]
Nocturia 0.49 ± 0.78 0.86 ± 1.14 0.199
0.20 [1.00] 0.64 [0.65]
Values reported are mean ± standard deviation and median [inter-quartile range]. *p values calculated using the Wilcoxon signed rank test;
†still statistically significant after sharpened Bonferroni adjustment. PFE = pelvic floor exercise; ITT = interferential therapy.
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we were unable to locate any literature that used this
variable as the outcome measure, indicating a need for
further research. Although the difference in the numbers
of patients with improvement (3 vs 6) between the two
groups was not significant, the p value was close enough
to 0.05 that one could conclude there was a trend that
ITT did have an additional effect over PFE alone. The
non-significant result was most likely due to low power.
Nevertheless, if only 50% of patients could be better off,
then there is certainly room for improvement, which
requires further research. The same pattern of difference
in change (i.e. the improvement rate with ITT + PFE was
twice that with PFE alone) was observed for urge, except
that 67% of participants in the ITT + PFE group improved.
Whether 67% is a high enough improvement rate is
debatable and subject to interpretation and the
expectation of individual clinicians.
The pad weighing test showed that in the PFE group,
five subjects achieved complete continence, two subjects
improved, two subjects remained the same and one had
increased leakage. In the ITT + PFE group, six subjects
achieved complete continence, four improved and one
remained the same. These results are consistent with
those reported previously [21]. The large difference in
mean improvement (85.1 ±  150 vs 4.3 ± 8.4) was
obviously attributable to an outlier in the ITT + PFE
group (380 units pre-treatment, which could be explained
by the effect of herbal diuretics taken without the
knowledge of the investigators until after data collection
was complete, and 2.0 units post-treatment). Never-
theless, the difference in median improvement in the
ITT + PFE group was almost twice that in the PFE group
(4.5 vs 2.5). This, together with the fact that the calculated
p value was close to the 0.05 cut-off point, leads to the
preliminary conclusion that there is an additional effect
with ITT. It is certainly worth conducting a larger and
more powerful study. The pattern for nocturia was
similar, so we will not repeat the discussion on that
outcome measure here.
In the PFE group, five subjects reported improvement
but the rest reported an increase in frequency. These
results are similar to those reported before [20]. In
contrast, 10 participants in the ITT + PFE group reported
improvement while one reported no change. Not only
was the difference in improvement statistically significant,
it was clinically substantial (1.8 vs 0.07 units). However,
Dougall reported a reduction in frequency after 12
treatments of ITT alone [22].
One limitation of the study was that it did not have a
third group, ITT alone, for comparison purposes. This has
clinical implications for the increasing elderly population
since many of them find it difficult to follow instructions
for PFE. However, the long-term effect of any intervention
modality is probably as important as, if not more important
than, short-term efficacy. Moreover, whether ITT is
tolerable in the longer term remains unknown. From
that perspective, PFE training appears to be an
indispensable intervention strategy for all sufferers of
stress and urge incontinence, especially because it is
inexpensive and can easily be practised at home.
Another major limitation of the study is the small
sample size. The power for some of the outcome variables
was as low as 0.2 or 0.3. Power analysis indicated that 70
subjects would be needed for each group for all variables
to be statistically significant. However, a detailed look at
the means and p values revealed that apart from the
perineometer reading, there was a trend to substantial
differences in favour of the ITT + PFE group. On the other
hand, this trend of short-term superiority does not
necessarily imply long-term effectiveness. If resources
can be generated, we plan to conduct a follow-up study
by interviewing the participants at 3- to 6-month intervals
to determine the duration of the effects.
This study only examined the effectiveness of the two
treatment regimes. The cost-benefit or cost-utility of
different treatment modalities has yet to be investigated.
In addition, including quality-of-life measures as outcome
variables has become the norm for studies on health care
interventions. This should be considered when further
evaluations are made.
All in all, this study demonstrated that ITT could
potentially have an additional effect in the treatment of
urinary stress and urge incontinence when prescribed
together with PFE.
Table 3. Comparison of categorical variables between the two regimes
Variable Improvement* PFE ITT + PFE p
n (%) n (%)
Stop/Start test Yes 3 (25) 6 (50) 0.200
No 9 (75) 6 (50)
Urge Yes 4 (33) 8 (67) 0.110
No 8 (67) 4 (33)
*Improvement was defined as from level 3 to 2 or 1, or from level 2 to 1. PFE = pelvic floor exercise; ITT = interferential therapy.
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